# Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia

> **NCT03389724** · PHASE3 · COMPLETED · sponsor: **Children's Cancer Hospital Egypt 57357** · enrollment: 245 (actual)

## Conditions studied

- Cardiotoxicity
- Acute Myeloid Leukemia in Children
- Bone Tumor

## Interventions

- **DRUG:** Capoten®

## Key facts

- **NCT ID:** NCT03389724
- **Lead sponsor:** Children's Cancer Hospital Egypt 57357
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-14
- **Primary completion:** 2021-11-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03389724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03389724, "Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03389724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*